These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23435146)

  • 1. Successful treatment of severe hepatorenal syndrome with living donor liver transplantation.
    Demirbas BT; Piskin T; Dayangac M; Yaprak O; Oklu L; Yuzer Y; Tokat Y
    Hepatogastroenterology; 2012 Oct; 59(119):2305-6. PubMed ID: 23435146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis.
    Fagundes C; Ginès P
    Am J Kidney Dis; 2012 Jun; 59(6):874-85. PubMed ID: 22480795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical management of hepatorenal syndrome.
    Davenport A; Ahmad J; Al-Khafaji A; Kellum JA; Genyk YS; Nadim MK
    Nephrol Dial Transplant; 2012 Jan; 27(1):34-41. PubMed ID: 22287700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate recovery of renal function after orthotopic liver transplantation in a patient with hepatorenal syndrome requiring hemodialysis for more than 8 months.
    Storm C; Bernhardt WM; Schaeffner E; Neuhaus R; Pascher A; Neuhaus P; Hasper D; Frei U; Kahl A
    Transplant Proc; 2007 Mar; 39(2):544-6. PubMed ID: 17362778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatorenal syndrome.
    Cárdenas A; Arroyo V
    Ann Hepatol; 2003; 2(1):23-9. PubMed ID: 15094702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatorenal syndrome].
    Pillebout E
    Nephrol Ther; 2014 Feb; 10(1):61-8. PubMed ID: 24388293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies.
    Meltzer J; Brentjens TE
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):139-44. PubMed ID: 20124895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of hepatorenal syndrome.
    Carl DE; Sanyal A
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):207-26. PubMed ID: 19305378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatorenal syndrome].
    Radziszewski A; Sułowicz W
    Przegl Lek; 2006; 63(7):573-8. PubMed ID: 17203812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatorenal syndrome.
    Bataller R; Arroyo V; Ginès P; Sort P
    Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation.
    Wong F; Leung W; Al Beshir M; Marquez M; Renner EL
    Liver Transpl; 2015 Mar; 21(3):300-7. PubMed ID: 25422261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatorenal syndrome.
    Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
    Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatorenal syndrome].
    Lautrette A; Liotier J; Deteix P; Souweine B
    Nephrol Ther; 2009 Apr; 5(2):150-6. PubMed ID: 18514053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential treatment of hepatorenal syndrome and posthepatic cirrhosis by intrahepatic portosystemic shunt (TIPSS) and liver transplantation.
    Lerut J; Goffette P; Laterre PF; Donataccio M; Reynaert MS; Otte JB
    Hepatogastroenterology; 1995; 42(6):985-7. PubMed ID: 8847056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
    Wong F; Raina N; Richardson R
    Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatorenal syndrome in patients with liver cirrhosis].
    Zaza S; Bonny O; Liaudet L
    Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The therapy of the hepatorenal syndrome in liver cirrhosis].
    Biecker E; Brensing KA; Perz J; Woitas R; Sauerbruch T
    Dtsch Med Wochenschr; 1999 Sep; 124(36):1039-42. PubMed ID: 10506842
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatorenal syndrome: pathogenesis and treatment].
    Ashkenazi E; Ilan Y; Shoval D
    Harefuah; 2007 Jun; 146(6):475-9, 499. PubMed ID: 17760404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.